Dabigatran‐induced esophagitis with full circumferential blue pigmentation
Abstract Dabigatran is a useful and widely used drug for stroke prevention in patients with atrial fibrillation. However, it has been reported to cause esophagitis. Herein, we report the case of a 77‐year‐old man with dabigatran‐induced esophagitis with blue pigmentation, which is known to be a rare...
Saved in:
| Main Authors: | Tomonori Araki, Kohei Hayashi, Yuki Sonoda, Takuya Honda, Yoshifumi Imamura, Yuji Koide, Hisayuki Hamada, Kazuhiko Nakao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-04-01
|
| Series: | DEN Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/deo2.271 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idarucizumab more effectively reverses the anticoagulant effects of dabigatran acylglucuronide than dabigatran
by: Jong-Min Kim, et al.
Published: (2025-07-01) -
Pharmacokinetics and Pharmacogenetics of Dabigatran
by: A. V. Savinova, et al.
Published: (2021-03-01) -
IDARUCIZUMAB, A SPECIFIC REVERSAL AGENT FOR DABIGATRAN: THE PRESENT-DAY KNOWLEDGE
by: Olga O. Shakhmatova
Published: (2018-12-01) -
HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. V. Moiseev
Published: (2015-12-01) -
UGT2B15 single nucleotide polymorphism reduces dabigatran acylglucuronide formation in humans
by: Jin-Woo Park, et al.
Published: (2025-01-01)